Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

GeoVax Labs (GOVX) Shares Outstanding (Weighted Average) (2016 - 2025)

GeoVax Labs' Shares Outstanding (Weighted Average) history spans 16 years, with the latest figure at $3.9 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $3.9 million for Q4 2025, up 1767.58% from a year ago — trailing twelve months through Dec 2025 was $3.9 million (up 1767.58% YoY), and the annual figure for FY2025 was $3.9 million, down 41.45%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $3.9 million at GeoVax Labs, down from $20.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $20.3 million in Q3 2025 to a low of $207482.0 in Q4 2024.
  • The 5-year median for Shares Outstanding (Weighted Average) is $6.5 million (2023), against an average of $8.0 million.
  • The sharpest move saw Shares Outstanding (Weighted Average) surged 11108354.17% in 2021, then plummeted 96.86% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $6.1 million in 2021, then plummeted by 81.45% to $1.1 million in 2022, then skyrocketed by 484.84% to $6.6 million in 2023, then plummeted by 96.86% to $207482.0 in 2024, then soared by 1767.58% to $3.9 million in 2025.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $3.9 million, $20.3 million, and $10.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.